Preemptive simultaneous pancreas kidney transplantation has survival benefit to patients
Enrique Montagud‐Marrahí(Hospital Clínic de Barcelona), Pedro Ventura‐Aguiar(Hospital Clínic de Barcelona), Jimena Del Risco-Zevallos(Hospital Clínic de Barcelona), María José Ramírez-Bajo(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Enric Esmatjes, Joana Ferrer(Instituto de Salud Carlos III), F Oppenheimer(Hospital Clínic de Barcelona), Frederic Cofán(Hospital Clínic de Barcelona), Antoni J. Amor(Hospital Clínic de Barcelona), Núria Esforzado(Hospital Clínic de Barcelona), Judit Cacho(Hospital Clínic de Barcelona), Fritz Diekmann(Hospital Clínic de Barcelona), Josep M. Campistol(Universitat de Barcelona), Matthew Cooper(Medical College of Wisconsin), David Cucchiari(European Association of Urology), Evelyn Hermida(Hospital Clínic de Barcelona), Mireía Musquera(Surgical Specialties (Canada)), Beatriu Bayés(Hospital Clínic de Barcelona), Elena Cuadrado‐Payán(Hospital Clínic de Barcelona), Ignacio Revuelta(Hospital Clínic de Barcelona), Vicens Torregrosa(Hospital Clínic de Barcelona)
Cited by 12
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k
Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT‐EXT Study)
|American Journal of Transplantation|2010|566
In Vivo Activation of a Conserved MicroRNA Program Induces Mammalian Heart Regeneration
|Cell stem cell|2014|201
Robot-assisted Kidney Transplantation: The European Experience
|European Urology|2017|143